Phasing-in RHD Genotyping

Overview

Journal Arch Pathol Lab Med

Specialty Pathology

Date 2014 May 3

PMID 24786114

Citations 4

Authors

Willy A Flegel

Susan D Roseff

Ashok Tholpady

Affiliations

Soon will be listed here.

Citing Articles

Blood Group Testing.

Li H, Guo K Front Med (Lausanne). 2022; 9:827619.

PMID: 35223922 PMC: 8873177. DOI: 10.3389/fmed.2022.827619.

Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors.

El Housse H, El Wafi M, Ouabdelmoumene Z, Zarati F, Alid R, Nourichafi N Blood Transfus. 2018; 17(2):151-156.

PMID: 30418133 PMC: 6476734. DOI: 10.2450/2018.0153-18.

Molecular immunohaematology round table discussions at the AABB Annual Meeting, Denver 2013.

Flegel W, Castilho L, Delaney M, Klapper E, Moulds J, Noizat-Pirenne F Blood Transfus. 2014; 13(3):514-20.

PMID: 25545874 PMC: 4614304. DOI: 10.2450/2014.0213-14.

It's time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group.

Sandler S, Flegel W, Westhoff C, Denomme G, Delaney M, Keller M Transfusion. 2014; 55(3):680-9.

PMID: 25438646 PMC: 4357540. DOI: 10.1111/trf.12941.

References

Wang D, Lane C, Quillen K . Prevalence of RhD variants, confirmed by molecular genotyping, in a multiethnic prenatal population. Am J Clin Pathol. 2010; 134(3):438-42. DOI: 10.1309/AJCPSXN9HQ4DELJE. View

Denomme G, Wagner F, Fernandes B, Li W, Flegel W . Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion. 2005; 45(10):1554-60. DOI: 10.1111/j.1537-2995.2005.00586.x. View

Fasano R, Monaco A, Meier E, Pary P, Lee-Stroka A, Otridge J . RH genotyping in a sickle cell disease patient contributing to hematopoietic stem cell transplantation donor selection and management. Blood. 2010; 116(15):2836-8. PMC: 2974591. DOI: 10.1182/blood-2010-04-279372. View

Flegel W, Denomme G, Yazer M . On the complexity of D antigen typing: a handy decision tree in the age of molecular blood group diagnostics. J Obstet Gynaecol Can. 2007; 29(9):746-52. DOI: 10.1016/s1701-2163(16)32606-8. View

Flegel W, von Zabern I, Doescher A, Wagner F, Strathmann K, Geisen C . D variants at the RhD vestibule in the weak D type 4 and Eurasian D clusters. Transfusion. 2009; 49(6):1059-69. PMC: 10710224. DOI: 10.1111/j.1537-2995.2009.02102.x. View

Sandler S, Roseff S, Domen R, Shaz B, Gottschall J . Policies and procedures related to testing for weak D phenotypes and administration of Rh immune globulin: results and recommendations related to supplemental questions in the Comprehensive Transfusion Medicine survey of the College of American.... Arch Pathol Lab Med. 2014; 138(5):620-5. DOI: 10.5858/arpa.2013-0141-CP. View

Cruz B, Chiba A, Moritz E, Bordin J . RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med. 2012; 22(2):84-9. DOI: 10.1111/j.1365-3148.2011.01129.x. View

Sandler S, Li W, Langeberg A, Landy H . New laboratory procedures and Rh blood type changes in a pregnant woman. Obstet Gynecol. 2012; 119(2 Pt 2):426-428. DOI: 10.1097/AOG.0b013e31823f6f76. View

Flegel W, Wagner F . Molecular genetics of RH. Vox Sang. 2000; 78 Suppl 2:109-15. View

10.

McGann H, Wenk R . Alloimmunization to the D antigen by a patient with weak D type 21. Immunohematology. 2010; 26(1):27-9. View

11.

Sandler S, Gottschall J . Postpartum Rh immunoprophylaxis. Obstet Gynecol. 2012; 120(6):1428-38. DOI: 10.1097/aog.0b013e3182742eba. View

12.

Flegel W . The genetics of the Rhesus blood group system. Blood Transfus. 2009; 5(2):50-7. PMC: 2535884. DOI: 10.2450/2007.0011-07. View

13.

Garratty G . Do we need to be more concerned about weak D antigens?. Transfusion. 2005; 45(10):1547-51. DOI: 10.1111/j.1537-2995.2005.00625.x. View

14.

Moussa H, Tsochandaridis M, Chakroun T, Jridi S, Abdelneji B, Hmida S . Molecular background of D-negative phenotype in the Tunisian population. Transfus Med. 2012; 22(3):192-8. DOI: 10.1111/j.1365-3148.2012.01142.x. View

15.

Wagner F, Frohmajer A, Ladewig B, Eicher N, Lonicer C, Muller T . Weak D alleles express distinct phenotypes. Blood. 2001; 95(8):2699-708. View

16.

Schmid P, von Zabern I, Scharberg E, Wagner F, Flegel W . Specific amino acid substitutions cause distinct expression of JAL (RH48) and JAHK (RH53) antigens in RhCE and not in RhD. Transfusion. 2010; 50(1):267-9. PMC: 3482507. DOI: 10.1111/j.1537-2995.2009.02446.x. View

17.

Pham B, Roussel M, Peyrard T, Beolet M, Jan-Lasserre V, Gien D . Anti-D investigations in individuals expressing weak D Type 1 or weak D Type 2: allo- or autoantibodies?. Transfusion. 2011; 51(12):2679-85. DOI: 10.1111/j.1537-2995.2011.03207.x. View

18.

Wagner F, Gassner C, Muller T, Schonitzer D, Schunter F, Flegel W . Molecular basis of weak D phenotypes. Blood. 1998; 93(1):385-93. View

19.

Flegel W . How I manage donors and patients with a weak D phenotype. Curr Opin Hematol. 2006; 13(6):476-83. DOI: 10.1097/01.moh.0000245694.70135.c3. View